Abstract
Platelet-activating factor (PAF) activates human platelets by binding to a putative PAF receptor which evokes the rapid formation of inositol-1,4,5-trisphosphate (IP3) by phospholipase C mediated phosphatidylinositol-4,5-bisphosphate (PIP2) hydrolysis. Stimulation of [3H]inositol-labeled human platelets by PAF (1 nM-1μM) resulted in a concentration-dependent increase of intracellular IP3, IP2 and inositolmonophosphate (IP1). IP1 levels increased up to three-fold upon maximum stimulation by 100 nM PAF. The EC50 concentration for PAF was 1.2±0.3 nM. Addition of the hetrazepinoic PAF antagonist, WEB 2086, inhibited PAF stimulated hydrolysis of PIP2 in a dose-dependent manner. WEB 2086 (100 μM) blocked inositol-1,4,5-trisphosphate formation down to baseline levels (IC50=33±12 μM WEB 2086). In thrombin and ADP stimulated platelets, inositol phosphate (IP) generation was not influenced by WEB 2086. It is concluded that WEB 2086 selectively antagonizes PAF-induced increases in IP and does not interfere directly with intracellular signal transduction. Instead, WEB 2086, which has been shown to bind specifically and with high affinity (Ki 15 nM) to human platelets, acts as a competitive antagonist at the PAF receptor level.
Similar content being viewed by others
Abbreviations
- ADP:
-
adenosine diphosphate
- DAG:
-
diacylglycerol
- IP3 :
-
inositol-1,4,5-trisphosphate
- IP:
-
inositol phosphates
- PAF:
-
platelet-activating factor, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine
- PIP2 :
-
phosphatidylinositol-4,5-bisphosphate
- PKC:
-
protein kinase C
- PLC:
-
phospholipase C
References
Braquet, P., Touqui, L., Shen, T.Y., and Vargaftig, B.B. (1987)Pharmacol. Rev. 39, 97–145.
Valone, F.H., Coles, E., Reinhold, V.R., and Goetzl, E.J. (1982)J. Immunol. 129, 1637–1641.
Williams, K.A., and Haslam, R.J. (1984)Biochim. Biophys. Acta 770, 216–223.
Houslay, M.D., Bojanic, D., and Wilson, A. (1986)Biochem. J. 234, 737–740.
Shukla, S.D., and Hanahan, D.J. (1983)Arch. Biochem. Biophys. 224, 626–629.
O'Rourke, F.A., Halenda, S.P., Zavoico, G.B., and Feinstein, M.B. (1985)J. Biol. Chem. 260, 956–962.
Vargaftig, B.B., Chignard, M., and Benveniste, J. (1981)Biochem. Pharmacol. 30, 263–271.
Siess, W., Weber, P.C., and Lapetina, E.G. (1984)J. Biol. Chem. 259, 8286–8292.
Shukla, S.D., Franklin, C.C., and Carter, M.G. (1987)Biochim. Biophys. Acta 929, 134–141.
Huang, E.M., and Detriller, T.C. (1986) inBiochemistry of Platelets (Phillipps, D.R., and Shulman, M.A., eds.), pp. 1–68. Academic Press, New York.
Casals-Stenzel, J., Muacevic, G., and Weber, K.H. (1987)J. Pharmac. Exp. Ther. 241, 947–981.
Heuer, H., Birke, F.W., Casals-Stenzel, J., and Weber, K.H. (1989)Prostaglandins 35, 838 (Abstract).
Birke, F.W., and Weber, K.H. (1988)Clin. Exp. Pharmacol. Physiol. Suppl. 13, 2 (Abstract).
Ukena, D., Dent, G., Birke, F.W., Robaut, C., Sybrecht, G.W., and Barnes, P. (1988)FEBS LETT. 228, 285–289.
Dent, G., Ukena, D., Chanez, P., Sybrecht, G., and Barnes, P. (1989)FEBS LETT. 244, 365–368.
Ukena, D., Kroegel, C., Kent, G., Jukawa, T., Sybrecht, G., and Barnes, P. (1989)Biochem. Pharmacol. 38, 1702–1705.
Berridge, M.J., Dawson, R.M.C., Downes, C.S., Heslop, G.P., and Irvine, R.F. (1983)Biochem. J. 212, 473–482.
Rominger, K.L., and Albert, H.J. (1985)Drug Research 35, 415–420.
Abdel-Latif, A.A. (1986)Pharmacol. Rev. 38, 227–272.
Shukla, S.D., Morrison, W.J., and Dhar, A. (1989)Molec. Pharmacol. 35, 409–413.
Shukla, S.D. (1985)Arch. Biochem. Biophys. 240, 674–681.
Simon, M.F., Chap, H., Braquet, P., and Douste-Blazy, L. (1989)Thromb. Res. 45, 299–309.
Nishizuka, Y. (1984)Nature 308, 693–698.
Uhing, R.J., Prpic, V., Hollenbach, P.W., and Adams, D.O. (1989)J. Biol. Chem. 264, 9224–9230.
Barzaghi, G., Saran, H.M., and Mong, S. (1989)J. Pharmacol. Exp. Ther. 248, 559–566.
Block, L.H., Imhof, E., and Perrucheud, A.P. (1988)Am. Rev. Respir. Dis. 137, 235.
Pretolani, M., Ferrer-Lopez, P., and Vargaftig, B.B. (1989)Biochem. Pharmacol. 28, 1373–1384.
Author information
Authors and Affiliations
About this article
Cite this article
Birke, F.W., Ensinger, H.A. Inhibition by the PAF antagonist WEB 2086 of PAF induced inositol-1,4,5-trisphosphate production in human platelets. Lipids 26, 1050–1053 (1991). https://doi.org/10.1007/BF02536500
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536500